Infinity Pharmaceuticals, Inc. (OTCPK: INFI.Q)
Health Care · Biotechnology · US
$0.00
-99.00% today · 0.0% 1Y
Infinity Pharmaceuticals, Inc. (OTCPK: INFI.Q) operates in the Biotechnology industry within the Health Care sector. The company is valued at $91.00 and employs 30 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
Tweenvest scores Infinity Pharmaceuticals, Inc. across four factors: quality 21/100, value 45/100, growth 0/100. Its strongest factor is value.
INFI.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $91.00
- Revenue (TTM)
- $2.57M
- P/E
- —
- EPS
- -0.46
- Dividend yield
- —
- Beta (5Y)
- 8.00
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 90.76M
- Employees
- 30
- Next earnings
- —
About Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts.
- ISIN
- US45665G3039
- Founded
- 1995
- Listed since
- Jul 28, 2000
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| NexImmune, Inc.OTCPK: NEXI | $139.00 | $— | — |
| PsyBio Therapeutics Corp.OTCPK: PSYB.F | $133.00 | $— | — |
| Marizyme, Inc.OTCPK: MRZM | $132.00 | $— | — |
| Lattice Biologics Ltd.OTCPK: LBLT.F | $128.00 | $— | — |
| RenovaCare, Inc.OTCPK: RCAR | $87.00 | $0.00 | — |
| Statera Biopharma, Inc.OTCPK: STAB | $73.00 | $0.00 | -99.00% |
| Gelesis Holdings, Inc.OTCPK: GLSH.Q | $73.00 | $0.00 | — |
| Athersys, Inc.OTCPK: ATHX.Q | $62.00 | $0.00 | -90.00% |
Figures last refreshed Oct 4, 2026.